Sie sind auf Seite 1von 14

DAFTAR PUSTAKA

1. Leung DYM; Rhodes AR; Geha RS; Schneider L; Ring J. Atopic Dermatitis (atopic eczema). In Fitzpatrick et al (eds) Dermatology in General Medicine, fourth ed Mc Graw Hill 1992: 154360. Rajka G. On Definition and Framework of Atopic Dermatitis. Acta Derm Venereol (Stockh). 1989; Suppl 144: 15-19. Sudigdoadi. Molekul IgE pada sel Langerhans epidermal sebagai petanda diagnosis Dermatitis atopik. Disertasi, Universitas Pajajaran, Bandung Indonesia, 1995. Arnold, H; Odom, RB; James. Atopic Dermatitis, Eczema, Non Infectious immunodeficiency disorders. In Andrew diseases of the skin, 8th ed. WB Saunders Co. 1990: 66-88. Hanifin JM. 1996. Atopic Dermatitis. In Moschella SL and Hurley HJ (eds) Dermatology, third ed. WB Saunders : 441464. Champion, RH and Parish, WE. Atopic Dermatitis. In Rook, Wilkinson and Ebling (eds). Text Book of Dermatology, 5th ed Blackwell Scientific Publ. 1992: 589-610. Beltrani,VS. The Clinical Manifestation of Atopic Dermatitis. In Leung DYM (ed) Fom Pathogenesis to Treatment, Texas, RG Landes Co. and Chapman & Hall: 1996:1 - 40. Sulzberger, MB and Voughn, WR. Expriments in Silk Hypersensitivity and the Inhalation of Allergen in Atopic Dermatitis (Neurodermatitis Disseminata). Allergy, 1934; 5: 554 - 580. Jones SM and Sampson HA. The Role of Allergen in Atopic Dermatitis. In Leung DYM (ed). Atopic Dermatitis: From Pathogenesis to Treatment, Texas, RG Landes Co. and Chapman & Hall, 1996: 41- 65.

2. 3.

4.

5. 6.

7.

8.

9.

10. Rothe MJ & Grant-Kels JM. Atopic Dermatitis; An Update. J Amer Acad Dermatol, 1996; 25(1): 1- 13. 11. Siti Aisyah, B.: Dermatitis Atopik Pada Anak, dalam Soedigdoadi dkk (eds) Dermatitis Atopik, Makalah lengkap Temu Ilmiah, 1997: l 65 - 85.

137

12. Svensson; Edman B and Moller H, A Diagnostic Tool for Atopic Dermatitis based on Clinical Criteria, Acta Derm Venereol Stockholm (suppl) 1985, 13. European Task Force on Atopic Dermatitis. Severity Scoring of Atopic Dermatitis:The SCORAD Index, Dermatology 186; 1993: 23 - 31. 14. Bruijnzeel-Koomen CAFM; Mudde GC and Bruijnzeel PLB. New Aspect in the Pathogenesis of Atopic Dermatitis, Acta Derm Venereol (Stockh) Suppl, 1989; 144: 5863. 15. Leung DYM & Hamid Q. The Immunology of Atopic Dermatitis. In Leung DYM (eds), Atopic Dermatitis: From Pathogenesis to Treatment, Texas, RG Landes Co and Chapman & Hall; 1996: 113-144. 16. Tanaka Y; Tanaka M; Anan S and Yoshida H. Immunohistochemical Studies on Dust Mite Antigen in positive Reaction Site of Pacth Test. Acta Derm Venereol (Stockh) 1989; Suppl.144: 7-9. 17. Boguniewicz and Leung: Management of Atopic Dermatitis in Leung (ed) Atopic Dermatitis: from pathogenesis to treatment, RG Launders Co. 1996: 185-92. 18. Ring, J. Atopy: Condition, Disease or Syndrome? In Ruzicka, Ring and Przybilla (eds). Hand Book of Atoic eczema. SpringerVerlag Berlin, 1991: 1 - 8. 19. Wuthrich B. What is Atopy? Condition, Disease or a Syndrome? In Wuthrich, B (ed), The Atopy Syndrome in the Third Millenium. Curr Probl Dermatol, Basel, Karger, 1999; 28 : 1-8. 20. Vowels BR; Rook AH; Cassinn M and Zweiman B. Expression of IL-4 and IL-5 mRNA in developing cutaneous late phase reaction, J Allergy Clin Immunology, 1995: 92 - 96 21. Wildschut, EGL; Thepen, T; Bihari, IC et al. Evaluation of Atopic Patch Test and The Cutaneous Late Phase Reaction as Relavant Models for the Study of Allergic Inflammation in Patients with Atopic Eczema. J Allergy Clin Immunology, December 1996, volume 98, Number 6. http://www2.us.elsevierhealth.com/ scripts/om.dll/serve. 22. Ebisawa, H; Tachimoto, Y; Iikura, Y et al. Role of Cytokines and Chemokines in the Late Phase Reaction. In Oehling & Lopez (eds) Progress in Allergy and Clinical Immunology, 1997; 4: 1- 6. 138

23. Ishizaka, K; Ishizaka, T and Hornbrook, M. Allergen binding Activity of -E, -G and -A antibodies in sera of atopic patients J Immunol, 1967; 98: 490-501. 24. Bonini RA. Susceptibility genes for allergy and astma. Allergy, 1997; 52: 256 - 273. 25. Laan M. Analysis of T cell differention during the development of atopy in children. Thesis, Erasmus Universiteit Rotterdam, 1999. 26. Jones, CA; Holloway, JA and Warner, JO. Review article: Does atopic disease start in foetal life? Allergy, 2000; 55: 2 - 10. 27. Eliott, K and Forrest, S. Genetic of Atopic Dermatitis. In Bieber and Leung (eds) Atopic Dermatitis, Mercell Dekker, Inc. New York-Besel, 2002: 81-109. 28. Teer A I. The Atopic Diseases. In Sties, Terr and Parslow (eds) Basic Clinical Immunology, eight ed. Prentice-Hall Intern. Inc.1994: 327-46. 29. Wollenberg A; Karaft S; Oppel T; Bieber T. Atopic dermatitis: pathogenetic mechanisms, Clin Exp Dermatol, 2000; 25(7): 530-534. 30. Grewe M et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis, Immunology Today, 1998; 10: 359-361. 31. Thepen T et al. Biphasis response against aeroallergen in atopic dermatitis showing a switch from an initial TH2 response to a TH1 response in situ: An immunocytochemical study. J Allergy Clin Immunol, 1996; 97: 828-837. 32. Harijono, KS. Peran Interleukin 12 pada pengalihan respon imun TH2 ke TH1 pada dermatitis atopik. Studi in vitro paparan tungau debu rumah and IL-12 pada kultur Limfosit penderita dermatitis atopik. Disertasi, Program Pasca Sarjana Universitas Airlangga Surabaya, 2003. 33. Girolomoni G; Gianneti A; and Pastore S. Keratinocytes. In Bieber and Leung (eds) Atopic Dermatitis, Mercell Dekker Inc. New York-Besel. 2002 : 231-240. 34. Weller PF. Update up Cells and Cytokines, Human Eosinophils, J Allergy Clin Immunol, 1997; 100: 283-287. 139

35. Leiferman KM; Plager DA and Gleich GJ. Eosinophils and Atopic Dermatitis. In Bieber and Leung (eds). Atopic Dermatitis, Mercell Dekker Inc. New York-Besel. 2002: 327-356. 36. Sudigdo Adi. Pola T helper-1 dan T helper-2 pada Lesi Kulit Penderita Dermatitis Atopik. MDVI. 1999; vol. 26(3): 127-135. 37. Romagnani S. The Th1/Th2 paradigm, Immunology Today, 1997; 18(6): 263-266. 38. Sawai T; Ikai K; Uehara M. Elevate cyclic adenosine monophosphate phosphodiesterase actifity in peripheral blood mononuclear leucocytes from children with atopic dermatitis, Br J Dermatol ; 1995, 132(1): 22-24. 39. Okado M, Terui T; Honda M et al. Cutaneous late phase reaction in adult atopic dermatitis patients with high serum IgE antibody to Dermatophagoides farinae: Correlation with IL-5 production by allergen stimulated peripheral blood mononuclear cells, J Dermatol Science, 2003; 29: 73-84. 40. Zweimann B; Moskovitz AR; Allmen CV et al. Comparison of inflammatory Events during Developing Immunoglobulin EMediated Late Phase Reaction and Delayed Hypersensitivity Reactions, Clinical and Diagnostic Laboratory Immunology, 1998; ( 5): 574-577. 41. Terr, AI : Inflammation, in Stites, Terr and Parslow (eds) Basic Clinical Immunology, Prentice- Hall International Inc., 1994: 13740. 42. Costa, JJ; Weller, PF; Galli, SJ: The Cells of the Allergic Response Mast Cells, Basophils, and Eosinophils, JAMA, 1997; 278: 1815-22. 43. Leiferman, KM: Eosinophil Granule Proteins in Cutaneous Diseases in Gleich & Kay (eds) Eosinofil in Allergy and Inflammation, Marcel Dekker Inc., 1996 : 445-72. 44. Gleich; Abu Ghazaleh, and Glitz: Eosinophil Granule Proteins: Structure and Functions in Gleich and Kay (eds) Eosinofil in Allergy and Inflamation, Marcel Dekker Inc. 1994 : 1-20. 45. Capron M, et al: Eosinophil Membrane Receptors, Function of IgE and IgA Binding Molecul, in Gleich & Kay (ed) Eosinophil in Allergy & Immunology, Marcel Dekker Inc. 1994: 225-27.

140

46. Leiferman & Gleich: The Role of Eosinofils in Atopic dermatitis in Leungs (eds) Atopic Dermatitis: from Pathogenesis to treatment, RG. Landes Co., 1996: 145-83. 47. Parslow, TG: The Phagocytes: Neutrophil & Macrophages in Stites (ed) Basic Clinical Immunology, Prentice-Hall International Inc., (1994) p. 9 - 21. 48. Magnarin M. et al : A Role for Eosinophils in the pathogenesis of skin lesions in patients with food-sensitive in Allergens, IgE mediators, Inflammatory mechanism, J. Allergy Clin Immunol, (1995); 96 (2) : 200-08. 49. Bruinjzeel, PL; Knijper, PHM; Kapp, A et al: The involoment of Eosinophil in the patch test reaction to aero allergens in atopic Dermatitis. Its relevance for the Pathogenesis of AD, Clin, Exp Allergy, 1993; 23(2): 97-109. 50. Ackerman, SJ et al: Human Eosinofil Lysophopholipase, in Gleich & Kay (ed) Eosinofil in Allergy & Inflamation, Marcel Dekker Inc. 1994: 21. 51. Cheng, YF et al: Dermal Eosinophils in AD Undergo Cytolytic Degeneration, J Allergy Clin Immunol, 1997; 99 (5): 683-92. 52. Wuthrich; Joller-Jemelka; Kagi: Levels of Soluble ICAM-1 in Atopic Dermatitis, a new marker for monitoring the clinical activity? Allergy, 1995; 50 (1): 88-9. 53. Halmerbauer G, Frischer T, Koller D.Y: Monitoring of disease activity by measurement of inflammatory markers in atopic dermatitis in chilhood, Allergy 1997; 52: 765 - 69. 54. Schleimer, RP et al : The Role of Adhesion Molecules and Cytokines in Eosinophils Recruitment in Gleich & Kay (eds) Eosinophils in Allergy and Inflammation, Marcel Dekker Inc., 1994: 99114. 55. Krensky, A.M.: The Biology of the Chemokine RANTES in Oehling and Lopez (eds) Progress in Allergy and Clinicals Immunology vol 4, Hogrefe & Huber Publisher, 1997: 7-11. 56. Scweizer, RC: Modulation of Human Eosinophils Migration. Disertasi, Thesis University Utrecht, Faculty of Medicine, 1996. 57. Mengelers, HJJ: Priming and Activation of Eosinophils in Allergic Asthma, Disertasi, Thesis University Utrecht, Faculty of Medicine, 1995. 141

58. Oranje AP. Development of childhood eczema and its classification, Pediatri Allergy Immunol, 1995; 6 (Suppl 7): 31 - 35. 59. Tan BB, Weald D, Strickland I and Friendmenn PS. Doeble-Blind Controlled Trial of Effect of Housedust mite Allergen Avoidance on Atopic Dermatitis. Lancet; 1996: 15-18. 60. Werfel T and Kapp A. What Do We Know about the Etiopathology of the Intrinsic Type of Atopic Dermatitis? In Wuthrich, B (ed), The Atopy Syndrome in the Third Millenium. Curr Probl Dermatol, Basel, Karger, 1999; 28: 29-36. 61. Akdis C.A et al. Role of T Cells and Cytokines in the Intrinsic Form of Atopic Dermatitis. In Wuthrich, B (ed), The Atopy Syndrome in the Third Millenium. Curr Probl Dermatol, Basel, Karger, 1999; 28: 37-44. 62. Hamid Q, et al. In vivo expression of IL-12 and IL-13 in atopic dermatitis. J Allergy Clin Immunol, 1996; 98: 225-231. 63. Rajka & Langerland, Grading of the Severity of Atopic Dermatitis, Acta Derm Venereol (Stockh) Suppl, 1989; 144:13-14. 64. Juhlin L; Johansson SGO; Bennich H; Hogman C and Thyresson W. Immunoglobulin E in Dermatoses. Level in Atopic Dermatitis and Urticaria, Arch Derm, 100; 1969: 12-15. 65. Johnson E; Irons J.S.; Patterson R and Roberts M. Serum IgE Concentration in Atopic Dermatitis, Allergy Clin Immunol, 1994; 54: 94-99. 66. Jones HE; Inouye YC; Mc Gerity Jl and Lewis CW. Atopic disease and serum immunologlobulin-E, Brith J Dermatol, 1975; 92: 17-25. 67. Raine et al. In vivo vivo expression of cytokine receptor on RNA in Atopic Dermatitis, J Allergy Clin Immunol, 1998; 102: 245-50. 68. Sampson HA & Hanifin J. Atopic Dermatitis. In: Jordon RE, ed. Immunologic Diseases of the skin, first ed. California; 1991. Appletan & Lange, pp 229-238. 69. Salim EM. Tes Kulit, Pharos Bulletin, 1996; No. 1, hal. 1921. 70. Roitt A.; Brostoff J; Male, D. Hypersensitivity-type I, in Immunology, third edition, Mosby-Year Book Europe Ltd. Printed in Hongkong. 1993: 19.119.4

142

71. Larsen, MS. Epidemiology and socioeconomic Impact of Allergic Skin Diseases, in Leung & Greaves (eds) Allergic Skin Diseases, 2000; 1st ed, Marcel Dekker: 120. 72. Subaryo, R. Prediksi Klinis Dermatitis Kontak tangan pada pekerja dengan kondisi Diatesis Atopi Kulit, Disertasi 1999. Program Pascasarjana Universitas Indonesia. 73. American Medical Association. Evaluation of Permanent Impairment, The Skin. AMA, third printing 1985: 203-213 74. Platts-Mills TAE; Mitchell EB; Rowntree S; Chapman MD and Wilkins SR. The 75. Nanda Dewi, RW. 1993. Tungau Debu Rumah sebagai Faktor Pencetus Eksogen pada penderita Dermatitis Atopik di RSU DR Hasan Sadikin Bandung, Penelitian Karya Ilmiah Akhir untuk Dokter Spesialis I I.P. Kulit & Kelamin, Univ. Pajajaran Bandung. 76. Norris PG; Schofield O and Camp RDR. A study of the role of house dust mite in Atopic Dermatitis, Br J Dermatol, 1988;118: 435 40. 77. Tupker, RA; De Monchy JGR and Conraads, PJ et al. Induction of atopic dermatitis by inhalation of house-dust mite, Allergy and Clin Immunology, 97: 106470. role of dust mite allergens in atopic dermatitis, Clin Exp Dermatol, 1983; 8: 23347. 78. Wakugawa M; Nakagawa HIV; Yamada N and Tamaki K. Chronologic Analysis of Eosinophil Granule Protein Deposition and Cell Adhesion Molecule Expression in Mite- Allergen Induced Dermatitis in Atopic Subjects, Int Arch Allergy Immunol, 1996; 111(suppl): 511. 79. Harijono, K. Hubungan kadar IgE total dalam serum dengan eosinifil darah dan derajat penyakit pada penderita dermatitis atopik, Maj Dermato-Venereol. Indon. 2000; 27(3): 100104. 80. Verela P, Selores M, Gomes E, Silva E, Matos E et al. Immediate and delayed hypersensitivity to mite antigens in atopic dermatitis, Pediatr Dermatol, 1999; 16(1): 1-5. 81. Jung K, Linse F and Pals ST. Adhesion molecules in Atopic Dermatitis patch test elicited by house dust mite. Contact Dermatitis 1997; 37: 163-72.

143

82. Al-Frayh AS, Hasnain SM and Gad-El Rab MO. House Dust Mite Allergens in Saudi Arabia. Regional variations and immune response. Ann Saudi Mad 1997; 17(2): 156-60. 83. Lyon WF, House Dust Mites. Ohio State University Extension Fact Sheet 1991; Kenny Road, Columbus. 84. Klenerman, P and Lipworth, B. House Dust mite allergy, Net Doctor Co. UK, Health Advice, 2000. 85. Gutgesell C, Seubert A, Junghans V and Neumann CH. Inverse correlation of domestic exposure to dermatophagoides pteronyssinus antigen patch ttest reactivity in patient with atopic Dermatitis. Clin Exper Allergy 1999; 29(7): 920-27. 86. Kimura M, Tsuruta S, and Yoshida T. Unique profile of IL-4 and IFN- production by peripheral blood mononuclear cells in infants with atopic dermatitis. J Allergey Clin Immunol 1998; 102: 238-44. 87. Laan MP, Baert MRM, Astrid ECM et al. Differential mRNA expression and production of interleukin-4 and interferongamma in stimulated peripheral blood mononuclear cells of house dust moite-allergic patients. European Cytokine Network 1998; 9(1): 75-84. 88. Sager N, Feldman A, Schilling G et al. House Dust Mite-specific T cells in the skin of subjects with atopic dermatitis: Frequency and lymphokine profile in the allergen patch test. J Allergy Clin Imanual 1992; 89: 801-10. 89. Sujudi Y and Wisesa TW. Tungau debu rumah dan perannya pada dermatitis atopik anak. Maj Dermatol Vener Indon 2000; 27(4S): 36S-42S. 90. Aulung, A. Aspek Biologi dan Etiologi Tungau Debu Rumah, Simposium Penatalaksanaan pasien asma dengan perbaikan Kondisi Lingkungan, Jakarta, 1992. 91. Boguniewicz M and Leung DYM. Atopic Dermatitis, in Leung & Greaves (eds), Allergic Skin Diseases. 2000, 1st ed Marcel Dekker: 125170. 92. Kolmer H and Platts-Mills. The Role of Inhalant allergens in atopic dermatitis, in (Williams HC ed) Atopic Dermatitis, Cambridge Univ. Press. 2002: 185-92.

144

93. Matsuyama T, Urano K, Ohkido M et al. The Quantitative and Qualitative defact of CD4+CD45RO+ memory type T cells are involved in the abnormality of TH1 immunity in atopic dermatitis patients. Clin and Experimental Allergy 1999; 29: 687-94. 94. Campbell DE, Fryga AS, bol S and Kemp AS. Intracelluler interferon-gamma (IFN-gamma) production in normal children and children with atopic dermatitis. Related Articles, Books, Clin Exp Immunol 1999; Mar, 115(3): 377-82. 95. Jung T, Moessner R, Dieckhoof K et al. Mechanisms of deficient interferon gamma production in atopic disease. Clin Exp Allergy 1999; Jul. 29 (7): 912-9. 96. Werfel T, Morita A, Grewe M et al. Allergen specificity of skininfiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis. Journal Invest Dermatol, 1996; Dec, 107(6): 871-6 97. MIMS Dermatology Guide Dermatitis p A11-A20. Philippines 2003/2004. Atopic

98. Yamamoto S; Hamasaki Y; Ishii E; Ichimaru T and Miyasaki S. Unbalanced production of Interleukin-5 and Interleukin 2 in children with Atopic Deramtitis, Ann Allergy Astma Immunol 1997; 78: 517-23. 99. Campbell DT and Standley JC. Experimental and Quasy Experimental Design for Research, 1963; Rand Mc Nally College Publish Co. Chigago. 100. Kowalzick L; Kleinheinz A; Neuber K; Weichenthal M; Kohler I and Ring J. Elevated Serum Levels of Soluble Adhesion Molecules ICAM-1 and ELAM-1 in Patients with Severe Atopic Eczema and Influence of UVA 1 Treatment, Dermatol 1995; 190:14-8. 101. Koide M; Furukuwa F; Tokura Y; Shirahama S; Takigawa M. Evaluation of soluble cell adhesion molecules in Atopic Dermatitis, J Dermatol 1997; 24(2): 88-93. 102. Wolkerstorfer A, Laan MP, Savekoul HF et al. Soluble E-selectin, other markers of inflammation and disease severity in children with atopic dermatitis, Br J Dermatol, 1998; 138(3): 431-5.

145

103. Jung K; Linse F; Heller R; Moths C; Goebel R; Neuman C et al. Adhesion molecules in Atopic Dermatitis. VCAM-1 and ICAM1 expression is increase in healty appearing skin, Allergy 1996; 57(7): 452-60. 104. Miyasato M et al. Serum level of eosinophil cationic protein reflect the state of in vitro degranulation of blood hypodense eosinophil in Atopic Dermatitis. J Dermatol 1996: 23(6): 38288. 105. Konthen, PG. 2003. Komunikasi pribadi. 106. Putra, ST. Patofisiologi Tingkat Sel, dalam: Putra, Suharto, Soewandojo (eds). Patofisiologi Kedokteran, 1997; Cetakan I GRAMIK FU Unair, hal 1-42. 107. Oppenheim JJ. Foreword,. dalam: Thomson A. (ed). The Cytokine Handbook, 3rd ed. Academic Press Limited. 1998: xviiixxii. 108. Marsetyawan, HNES. Sitokin, Kuliah Defisiensi Biomol & Imunologi, TPPD Fak. Kedokteran Universitas Gajah Mada, 2000. 109. Vilcek J. The Cytokines: An Overvie, dalam: Thomson A. (ed). The Cytokine Handbook, 3rd ed. Academic Press Limited. 1998: 1 20. 110. Oppenheim JJ; Ruscetti FW & Faltynek C. Cytokines, dalam: Stites, Terr, Parslow editor. Basic Clinical Immunology, eighth ed. Prentice-Hall Intern. Inc. 1994: 105123. 111. Bharat BA and Puri RK. Cytokines Network, dalam: Bharat & Puri, (ed) Human Cytokines: Their Role in Disease and Therapy, Blackwell Science. Inc. 1995: 326. 112. Sventivanyi. The -adrenergic theory of the Atopic abnormality in Bronchial Asthma. J Allergy, 42, 1968: 203-32. 113. Claudy A. Neuromediators in dermatology, Pathol Biol (Paris), Dec 44, 1996: 888894. 114. Bellanti, J. Immunology, second ed. Philadelphia, WB Saunders Co. 1979: 341-431. 115. Mosmann TR and Sad S. Immunology Today, vol. 17(3), 1996: 138 47.

146

116. Chomarat P; Rybak ME and Banchereau J. Interleukin4, dalam: Thomson A. (ed). The Cytokine Handbook, 3rd ed Academic Press Limited. 1998: 133749. 117. Hillman GG and Haas GP. Role of Cytokines in Lymphocyte Functions. Dalam: Bharat & Puri, editor. Human Cytokines: Their Role in Disease and Therapy, Blackwell Science. Inc. 1995: 37-54. 118. Cambell DE; Kemp AS. Proliferation and production of interferongamma (IFN- ) and IL-4 in response to Staphylococcus aureus and staphylococcal superantigen in childhood atopic dermatitis, Clin Exp Immunol, 107(2), 1997: 392 7. 119. Bischoff SC. Regulation of human mast cells, basophils and eosinophils: Implications for allergic diseases. Dalam: Metcalfe editor. Award Book 2000, Pharmacia Allergy Research Foundation, 2000: 7-14. 120. Sanderson CJ. Interleukin5. Dalam: Thomson A. editor. The Cytokine Handbook, 3rd ed Academic Press Limited. 1998: 17596. 121. Siti Boedina K. Imunologi: Diagnosis dan Prosedur Laboratorium, edisi ketiga Balai Penerbit FKUI, Jakarta. 1996: 38 44. 122. Kapp A; Czech W; Krutmann J; Schopf E. Eosinophil cationic protein in sera of patients with atopic dermatitis, J Am Acad Dermatol; 24(4), 1991: 5558. 123. Malefyt R W & de Vries JE. Interleukin13. Dalam: Thomson A. editor. The Cytokine Handbook, 3rd ed Academic Press Limited. 1998: 42742. 124. Callard R and Gearing A. The Cytokine Facts Book, Academic Press Limited London NWI 7DX. 1994. 125. Jung T; Witzak K; Dieckhoff K; Zachmann K; Heidrich S; Aversa G; Neumann C. IFN-gamma is only partially restored by costimulation with IL-12, IL-2, IL-15, IL-18 or engagement of CD28, Clin Exp Allergy 29(2), 1999: 20716. 126. Schneider LC; Baz Z; Zarcone C and Zurakowski D. Long-term therapy with recombinant interferon-gamma (rIFN-) for atopic dermatitis, Ann Allergy Asthma Immunol, 1998;80: 263 8.

147

127. Stevens SR; Hanifin JM; Hamilton T; Tofte SJ; Cooper KD. Longterm effectiveness and safety of recombinat human interferongamma therapy for atopic dermatitis despite unchanged serum IgE levels, Arch Dermatol, 1998;1434 (7): 799804 128. Sudigdoadi. Dermatitis Atopik: Paradigma Baru Patogenesis Dermatitis Astopik dengan menggunakan Data Loka, dalam Sudigdoadi dkk, (eds) Buku Makalah Lengkap Kursus Imunodermatologi I, Penerbit : KSID, Bandung, 2000:153-170. 129. Kanek, R; Matsu T; Iwatsuki K. Biphasic cytokine expression by cell clones from patients with atopic dermatitis with deferentincubatioon periods and strengths of stimuli, Fukushima J Med Sci 2001; 47(2): 51-62. 130. Lewis D. Allergy immunotherapy and inhibition of Th2 immune responses:a sufficient strategy? Curr Opin immunol 2002; 14(5): 644. 131. Matsumoto M; Itakura A; Tanaka A et al. Inability of IL-12 to downregulate IgE syntesis due to defective production of IFN-gamma in atopic NC/Nga mice. Immunol, 2001;167(10): 5955-62. 132. Habu Y; Seki S; Takayama E et al. The mechanism of the defective IFN-gamma response to bacterial toxins in an atopic dermatitis model, NC/Nga mice, and the therapeutic effect of IFN-gamma, IL-12, or IL-18 on dermatitis. J Immunol 2001; 166(9):5439-47. 133. Nachmias, D dan Nachmias C. Research methods in the social sciences, St Martins Press New York 3 rd edit. 1987. hal 185. 134. Lester, MR; Hofer, MF; Gately, M; Trumble, A and eung, DY. Down-regulating effects of IL-4 and IL-10 on the IFN-gamma response in atopic dermatitis, J Immunol 1995; 154(11): 617481. 135. Kondo N; Matsui E; Kaneko H et al, Role of IL-12 Receptor 2 Mutations in the Development of Atopy, Simposium: Ancedents of Allergic Disease-early Life Events. Allergy & Clinical Immunology International 2000. Supplement 1: 92-94. 136. Bratawidjaja, K. 1996. Molekul adhesi pada inflamasi alergi, tantangan baru untuk para klinikus, Maj Kedokt Indon. No. 5, 46: 223-228. 137. Gallin, JI. Inflammation. In Paul WE (ed) Fundamental Immunology, third ed New York, Raven Press. 1993: 10351044.

148

138. Mudigdo, A. Peran Patologi dalam pengembangan Ilmu Kedokteran Masa depan. Pidato Pengukuhan Guru Besar Fak. Kedokteran Univ. Sebelas Maret, 2004. 139. Constantinides, P. Pathobiology, Appleton & Lange, Norwalk, Connecticut., 1994: 133158. 140. Sudigdoadi. Inflamasi imunology, Kongres PERDOSKI, Surabaya, 1999: 811. Nasional IX

141. Sugiri, U dan Sudigdoadi. Kortikosteroid sebagai anti inflanasi, Naskah Lengkap Simposium dan Semiloka Peranan Imunologi dalam menghadapi Era Globalisasi, Bandung, 1998. 142. Cotran RS, Kumar,V, Robbin, SL et al. Robbins pathologic basis of diseases. 5 th WB Saunders Co. Philadelphia. 1994: 51-57. 143. Harijono, K. Reaksi atopi dan face late reaction, Advance on Immuno-Dermatology Course, Bandung 2003. 144. Klein, J. Immunology. Blackwell Scientific Publication, first published. Boston 1990: 451- 459. 145. Werth, V P. Systemic Glucocorticoids. In Fitzpatrick, Eizen, Walf, Freedberg, Austen (eds) Dermatology in General Medicine, 6th ed Mc Graw Hill Book Co. New York, 2000. 146. Parfitt, K. Corticosteroid. In Martindale The Complex Drugs Reference, 32nd Pharmaceutical Press. pp 1010-1047. 147. Fahey, TD. Anabolic-androgenic steroids: Mechanism of Action and Effect on Performance. In: T.D Fahey (ed) Encyclopedia of Sports Medicine and Science. Internet Sociaty for Sports Science, 1998; http: //sportsci.org. 148. Aberer, W and Wolf, K. 2002. Systemic Pharmacotherapy. In Bieber and Leung (eds) Atopic Dermatitis, Mercell Dekker Inc. New York-Besel. pp 589-607. 149. USPDI. Corticosteroids/Corticotropin. In: Drug Information for the Health Care Professional, United States Pharmacopeial Convention, Inc. 1995: 878894. 150. AHFS Drug Information, Methyl prednisolone. 2002: 2932-2934 151. Ramirez, HM; Kang, K; Seth, R et al. 2002. Cellulart aspects of Atopic Dermatitis: Overniew. In Bieber and Leung (eds) Atopic Dermatitis, Mercell Dekker, Inc. New York-Besel. pp 217-230. 149

152. Bos, JD; Das, PK and Kapsenberg, ML. The Skin Immun System. In Bos, JD (ed). Skin Immune System. CRC Press, Inc. 1990: 3-8. 153. Spergel, J.M and Schneider, L.C. 1997. Atopic Dermatitis, The Internet Journal of Asthma, Allergy and Immunology, vol 1, No 1. http://www.ispub.com/journals/IJAAI/Vol1N1/AD. htm

150